To this end, we investigated the correlation of the expressions of HOXD10 and its targets with PFS in stage II and III CRC patients (n = 66) treated with adjuvant 5-FU-based chemotherapy using a publicly available GEO dataset (GSE103479). This evidence concerns the gene HOXD10 and colorectal carcinoma.